CareDx Hit With $96M Infringement Verdict Over DNA Test IP
A Delaware jury has moved to award Natera over $96 million in damages after finding that rival CareDx infringed one of its patents through the sale of its DNA tests for...To view the full article, register now.
Already a subscriber? Click here to view full article